Healthcare provider profile · identity verified

Carl Anthony Violano, MD

Family Practice · GUILFORD, CT · NPI 1518151596

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	429	159
Rosuvastatin Calcium	Rosuvastatin Calcium	354	117
Amlodipine Besylate	Amlodipine Besylate	301	100
Levothyroxine Sodium	Levothyroxine Sodium	247	88
Losartan Potassium	Losartan Potassium	239	90
Lisinopril	Lisinopril	194	69
Metoprolol Succinate	Metoprolol Succinate	133	44
Lorazepam	Lorazepam	110	36
Alprazolam	Alprazolam	105	31
Meloxicam	Meloxicam	105	34
Hydrochlorothiazide	Hydrochlorothiazide	103	35
Simvastatin	Simvastatin	101	36
Allopurinol	Allopurinol	96	25
Tamsulosin Hcl	Tamsulosin Hcl	95	35
Omeprazole	Omeprazole	93	37
Sertraline Hcl	Sertraline Hcl	92	29
Metformin Hcl	Metformin Hcl	91	32
Zolpidem Tartrate	Zolpidem Tartrate	73	27
Pantoprazole Sodium	Pantoprazole Sodium	70	25
Escitalopram Oxalate	Escitalopram Oxalate	69	30
Trazodone Hcl	Trazodone Hcl	69	27
Ozempic	Semaglutide	64	21
Eliquis	Apixaban	62	23
Albuterol Sulfate Hfa	Albuterol Sulfate	59	26
Metformin Hcl Er	Metformin Hcl	59	23
Chlorthalidone	Chlorthalidone	58	20
Valsartan	Valsartan	58	20
Alendronate Sodium	Alendronate Sodium	57	18
Gabapentin	Gabapentin	53	24
Telmisartan	Telmisartan	47	16
Ezetimibe	Ezetimibe	46	17
Metoprolol Tartrate	Metoprolol Tartrate	45	14
Prednisone	Prednisone	43	27
Carvedilol	Carvedilol	42	11
Pravastatin Sodium	Pravastatin Sodium	42	20
Fluticasone Propionate	Fluticasone Propionate	38	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	36	13
Montelukast Sodium	Montelukast Sodium	36	15
Synthroid	Levothyroxine Sodium	36	13
Tramadol Hcl	Tramadol Hcl	36	15
Clonazepam	Clonazepam	34	12
Jardiance	Empagliflozin	33	suppressed
Duloxetine Hcl	Duloxetine Hcl	32	11
Hydralazine Hcl	Hydralazine Hcl	32	suppressed
Citalopram Hbr	Citalopram Hydrobromide	31	13
Fluoxetine Hcl	Fluoxetine Hcl	30	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	29	suppressed
Furosemide	Furosemide	29	suppressed
Mounjaro	Tirzepatide	29	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	12
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	28	suppressed
Famotidine	Famotidine	27	suppressed
Atenolol	Atenolol	26	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	20
Valacyclovir	Valacyclovir Hcl	25	14
Benazepril Hcl	Benazepril Hcl	24	suppressed
Ibuprofen	Ibuprofen	22	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	20
Irbesartan	Irbesartan	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Clopidogrel	Clopidogrel Bisulfate	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	18	suppressed
Ammonium Lactate	Ammonium Lactate	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Finasteride	Finasteride	17	suppressed
Potassium Chloride	Potassium Chloride	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	15
Azithromycin	Azithromycin	16	14
Bupropion Xl	Bupropion Hcl	16	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	16	suppressed
Pregabalin	Pregabalin	15	suppressed
Glipizide Er	Glipizide	14	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Amoxicillin	Amoxicillin	13	13
Colchicine	Colchicine	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Ramipril	Ramipril	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Temazepam	Temazepam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error